Search Results - "Atwa, Gamal M.K."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Ameliorative Effect of Dabigatran on CFA-Induced Rheumatoid Arthritis via Modulating Kallikrein-Kinin System in Rats by Youssef, Mahmoud E., Abdel-Reheim, Mustafa A., Morsy, Mohamed A., El-Daly, Mahmoud, Atwa, Gamal M. K., Yahya, Galal, Cavalu, Simona, Saber, Sameh, Ahmed Gaafar, Ahmed Gaafar

    “…Rheumatoid arthritis is an autoimmune disease that affects joints, leading to swelling, inflammation, and dysfunction in the joints. Recently, research efforts…”
    Get full text
    Journal Article
  2. 2

    Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines by Badawi, Waleed A., Samir, Mohamed, Fathy, Hazem M., Okda, Tarek M., Noureldin, Mohamed H., Atwa, Gamal M.K., AboulWafa, Omaima M.

    Published in Bioorganic chemistry (01-09-2023)
    “…•Pyrimidine-based hydrazones were designed and synthesized.•Novel pyrimidine-based hydrazones were screened against two breast adenocarcinoma cells while the…”
    Get full text
    Journal Article
  3. 3

    Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma by Elsayed, Mahmoud, Okda, Tarek, Atwa, Gamal, Omran, Gamal, Abd Elbaky, Atef, Ramadan, Abd

    Published in Pharmaceutics (02-05-2021)
    “…Luteolin (LUT) is a natural flavonoid with low oral bioavailability with restricted clinical applications due to its low solubility. LUT shows significant…”
    Get full text
    Journal Article
  4. 4

    Anti-Tumor Activity of Orally Administered Gefitinib-Loaded Nanosized Cubosomes against Colon Cancer by El-Shenawy, Ahmed A, Elsayed, Mahmoud M A, Atwa, Gamal M K, Abourehab, Mohammed A S, Mohamed, Mohamed S, Ghoneim, Mohammed M, Mahmoud, Reda A, Sabry, Shereen A, Anwar, Walid, El-Sherbiny, Mohamed, Hassan, Yasser A, Belal, Amany, Ramadan, Abd El Hakim

    Published in Pharmaceutics (01-02-2023)
    “…Gefitinib (GFT) is a tyrosine kinase inhibitor drug used as a first-line treatment for patients with advanced or metastatic non-small cell lung, colon, and…”
    Get full text
    Journal Article
  5. 5

    A Novel Role of Galectin-3 and Thyroglobulin in Prognosis and Differentiation of Different Stages of Thyroid Cancer and Elucidation of the Potential Contribution of Bcl-2, IL-8 and TNF-α by Okda, Tarek M, Atwa, Gamal M K, Eldehn, Ahmed Fathy, Dahran, Naief, Alsharif, Khalaf F, Elmahallawy, Ehab Kotb

    Published in Biomedicines (01-02-2022)
    “…Thyroid cancer is among the most prevalent cancers with different types and stages. New markers are required for the prognosis and diagnosis of the disease…”
    Get full text
    Journal Article